The Reliability and Validity of the Rhodes Index of Nausea, Vomiting and Retching in Postoperative Nausea and Vomiting

Kim, Tae Hee; Choi, Byung‐Moon; Chin, Ji Hyun; Lee, Moo Song; Kim, Dong Hee; Noh, Gyu Jeong

doi:10.4097/kjae.2007.52.6.s59

Cited by 20 publications

(15 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Moreover, we needed a more objective assessment tool for the degree of PONV. We selected the Rhodes index of nausea, vomiting, and retching (RINVR), as the reliability and validity of its Korean translated version has been confirmed [ 23 ].…”

Section: Discussionmentioning

confidence: 99%

“…The RINVR is a more suitable method for the quantitative and objective assessment of the degree of PONV felt by patients than the simple detection of the PONV occurrence or the subjective measurement of the degree of PONV using a visual analogue scale (VAS). The reliability and validity of the Korean translated version of the RINVR has already been established [ 23 ].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Effective Dose of Ramosetron for Prophylaxis of Postoperative Nausea and Vomiting in High-Risk Patients

Lee

Jeong

Kim

et al. 2015

BioMed Research International

View full text Add to dashboard Cite

Background. Postoperative nausea and vomiting (PONV) are common adverse events with an incidence of up to 80% in high-risk patients. Ramosetron, a selective 5-HT3 receptor antagonist, is widely used to prevent PONV. The purpose of this study was to evaluate the effective dose of ramosetron for the prevention of PONV in high-risk patients. Methods. Fifty-one patients were randomly allocated to 3 groups and were administered ramosetron 0.3 mg (group A), 0.45 mg (group B), or 0.6 mg (group C), at the end of their surgery. The episodes of PONV were assessed 1, 6, 24, and 48 hours after the injection and all the adverse events were observed. Results. The complete response rate in the postoperative period 6–24 hours after the anesthesia was higher in group C than in group A: 93% versus 44%. Group C's experience score of Rhodes index was lower than group A's: 0.81 ± 2.56 versus 3.94 ± 5.25. No adverse drug reaction could be observed in all groups. Conclusions. The effective dose of ramosetron to be injected for the near-complete prophylaxis of PONV 6 to 24 hours after surgery in high-risk patients is a 0.6 mg bolus injection at the end of the surgery.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Effective Dose of Ramosetron for Prophylaxis of Postoperative Nausea and Vomiting in High-Risk Patients

Lee

Jeong

Kim

et al. 2015

BioMed Research International

View full text Add to dashboard Cite

show abstract

“…Compared with the method of simply detecting PONV occurrence or with the method of measuring the degree of PONV subjectively using a visual analogue scale (VAS), RINVR is a more suitable method for quantitatively and objectively assessing the degree of PONV that patients may feel [3]. …”

Section: Introductionmentioning

confidence: 99%

Post-operative nausea and vomiting after gynecologic laparoscopic surgery: comparison between propofol and sevoflurane

Shinn

Lee

Moon

et al. 2011

Korean J Anesthesiol

View full text Add to dashboard Cite

BackgroundWe compared the incidence and degree of post-operative nausea and vomiting (PONV) in patients who received general anesthesia with propofol or sevoflurane using the Rhodes index of nausea, vomiting, and retching (RINVR) to assess the degree of PONV quantitatively and objectively during the post-anesthetic period.MethodsWe performed a prospective study involving 38 patients who underwent gynecologic laparoscopic surgery in our hospital between September 2008 and August 2009. Nineteen patients were anesthetized with propofol during the entire anesthetic period and the other 19 patients received 2.0 mg/kg of propofol intravenously, followed by sevoflurane inhalation. Three patients who were anesthetized with sevoflurane were excluded from the analysis because they were omitted during the survey. We studied the patients who had PONV and RINVR scores 1, 6, and 24 hours post-operatively.ResultsThe propofol group had a statistically lower incidence of PONV and lower RINVR scores in the following subclasses within 1 hour of surgery: symptom occurrence; symptom distress; and symptom experience.ConclusionsPropofol at induction and during maintenance of anesthesia can be used to prevent PONV within 1 hour post-operatively in patients undergoing gynecologic laparoscopic surgery.

show abstract

“…Observations nausea, vomiting performed for 12 hours, beginning after the administration of cisplatin. At the 12th, conducted interviews to patients with the method of measurement Index of Nausea, vomiting and Retching (Rhodes, 1996, Brearley, 2008, Kim et al, 2007, Wood et al 2010. Then to compare the effectiveness of granisetron and ondansetron and dexamethasone with dexamethasone do different test.…”

Section: Methodsmentioning

confidence: 99%

Comparison of the Antiemetic Effectiveness Between Granisetron and Dexamethasone With Ondansetron and Dexamethasone in Acute-Phase Chemotherapy Patients

Arfiani¹,

Susilo²,

Suprapti³

2017

FMI

View full text Add to dashboard Cite

Nausea and vomiting may occur in patients receiving chemotherapy, a condition referred to as chemotherapy-induced nausea and vomiting. The provision of combined dexamethasone and ondansetron or granisetron is the therapeutic management of acute phase nausea and vomiting in cytostatics with a high risk of nausea and vomiting. Granisetron has been known to have better pharmacokinetics and pharmacodynamics compared to ondansetron, so it is possible to have nausea and vomiting suppressing effect higher than that of ondansetron. This study aimed to compare antiemetic effectiveness of granisetron and dexamethasone with ondansetron and dexamethasone in acute-phase chemotherapy patients. This study was conducted in patients who received the combination of cisplatin-paclitaxel and cisplatin-fluorouracil, double-blind, with samples comprised new head and neck surgical oncology patients. Measurement of nausea and vomiting during the acute phase of chemotherapy was conducted using Index of Nausea, Vomiting, and Retching (INVR). Observation of nausea and vomiting in the patients was done during the first 12 hours after administration of cisplatin and interviews were conducted on h 12. Results showed that there was no difference in the effectiveness of nausea and vomiting suppression in the administration of granisetron and dexamethasone compared to ondanstron and dexamethasone in acute phase chemotherapy patients (p = 0.076).

show abstract

The Reliability and Validity of the Rhodes Index of Nausea, Vomiting and Retching in Postoperative Nausea and Vomiting

Cited by 20 publications

References 19 publications

Effective Dose of Ramosetron for Prophylaxis of Postoperative Nausea and Vomiting in High-Risk Patients

Effective Dose of Ramosetron for Prophylaxis of Postoperative Nausea and Vomiting in High-Risk Patients

Post-operative nausea and vomiting after gynecologic laparoscopic surgery: comparison between propofol and sevoflurane

Comparison of the Antiemetic Effectiveness Between Granisetron and Dexamethasone With Ondansetron and Dexamethasone in Acute-Phase Chemotherapy Patients

Contact Info

Product

Resources

About